Jenburkt Pharmaceuticals

quarterly
yearly
ParticularsSep '23Dec '23Mar '24Jun '24Sep '24
Revenue39.3937.0140.0333.9543.07
Expenses29.8529.1629.6723.8830.55
EBITDA10.208.5411.0410.7013.28
EBIT9.617.9110.4310.1712.64
Profit Before Tax9.547.8410.3610.0712.52
Net Profit7.325.407.887.429.60
Financial Ratios
Operating Profit Margin26.64%23.95%28.42%32.88%32.22%
Net Profit Margin19.12%15.14%20.29%22.80%23.29%
Earning Per Share (Diluted)16.5912.2517.8616.8021.75
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.5.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ